Clinical Trials

Clinical Trials: Find a Clinical Trial

At any time Memorial Sloan-Kettering Cancer Center is conducting hundreds of clinical trials to improve care for many types of cancer. Use the tool below to browse our clinical trials that are currently enrolling new patients. Each listing explains the purpose of the trial, the trial’s eligibility criteria, and how to get more information.

The list below includes clinical trials for adult cancers. Please visit our pediatric cancer care section to find a pediatric clinical trial.

Showing 241 - 260 of 449 trials
Title Investigatorsort icon Disease(s)
Understanding the Psychosocial Needs of Parents Who Have Lost a Child to Cancer
[Protocol 09-107] 		Lichtenthal, Wendy
  • Psychiatry & Behavioral Sciences
Development of Group Interventions for Breast Cancer Survivors
[Protocol 12-291] 		Lichtenthal, Wendy
  • Breast Cancer
  • Survivorship
Assessment of a Customized Computer Program for Reducing Fears of Breast Cancer Recurrence
[Protocol 11-204] 		Lichtenthal, Wendy
  • Breast Cancer
  • Psychiatry & Behavioral Sciences
  • Survivorship
A Phase I/II Study of Gemcitabine, Cisplatin, and MEK162 as Initial Treatment for Advanced Bile Duct or Gallbladder Cancer
[Protocol 13-004] 		Lowery, Maeve
  • Hepatobiliary
  • Upper Gastrointestinal
A Pilot Trial of Irinotecan, Temozolomide, and Bevacizumab plus High-Dose Chemotherapy for Newly Diagnosed Patients with Desmoplastic Small Round Cell Tumor
[Protocol 10-091] 		Magnan, Heather
  • Sarcomas
    • Soft Tissue Sarcoma
A Phase II Study of Cabozantinib versus Paclitaxel to Treat Recurrent or Persistent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
[Protocol 13-048] 		Makker, Vicky
  • Ovarian Cancer
A Phase II Study of MK-2206 in Patients with Recurrent or Advanced Endometrial Cancer Stratified by PIK3CA Mutation Status
[Protocol 11-071] 		Makker, Vicky
  • Endometrial and other Uterine Cancers
    • Endometrial Cancer
A Phase II Study of Dalantercept to Treat Recurrent or Persistent Endometrial Cancer
[Protocol 12-180] 		Makker, Vicky
  • Endometrial and other Uterine Cancers
    • Endometrial Cancer
A Phase II Trial of a WT-1 Vaccine in Patients with Acute Myeloid Leukemia
[Protocol 10-143] 		Maslak, Peter
  • Leukemia
    • Acute Myelogenous Leukemia
A Phase III Study of Ofatumumab versus Rituximab Salvage Chemoimmunotherapy Followed by Autologous Stem Cell Transplant in Relapsed or Refractory Diffuse Large B-Cell Lymphoma
[Protocol 11-079] 		Matasar, Matthew
  • Lymphoma
    • Non-Hodgkin's Lymphoma
A Pilot Study of Single-Dose Ipilimumab and/or Cryoablation in Women with Early-Stage Breast Cancer Scheduled for Mastectomy
[Protocol 11-202] 		McArthur, Heather
  • Breast Cancer
Use of Patient-Reported Outcomes to Facilitate Survivorship Care and Determine Risk of Adverse Outcomes in Cancer Survivors
[Protocol 12-185] 		McCabe, Mary
  • Colorectal Cancer
    • Colon Cancer
  • Prostate Cancer
    • Quality of Life
  • Survivorship
A Phase II Study of Repeat Breast-Preserving Surgery and 3D-Conformal Partial Breast Re-Irradiation for Local Recurrence of Breast Cancer
[Protocol 10-152] 		McCormick, Beryl
  • Breast Cancer
A Phase II Study of BKM120 in Patients with Recurrent Glioblastoma and an Activated PI3K Pathway
[Protocol 12-002] 		Mellinghoff, Ingo
  • Pediatric Brain Tumors
    • Brain Cancer
A Pilot Study of Weekly High-Dose Erlotinib for Recurrent High-Grade Gliomas with the EGFR variant III Mutation
[Protocol 10-125] 		Mellinghoff, Ingo
  • Brain Tumors, Primary
    • Gliomas
  • Pediatric Brain Tumors
    • Brain Cancer
A Phase I Study of Panitumumab in Children with Solid Tumors
[Protocol 08-020] 		Meyers, Paul
Genetic Variability as a Determinant of Chemotherapy Toxicity and Response in Pediatric Cancer and Bone Marrow Transplantation Patients
[Protocol 03-123] 		Meyers, Paul
  • Hematology
    • Hematologic Malignancies
  • Sarcomas
A Phase I Study of Anti-GD2 3F8 Antibody and Allogeneic Natural Killer Cells for High-Risk Neuroblastoma
[Protocol 09-011] 		Modak, Shakeel
  • Neuroblastoma
A Pilot Phase II Study of Targeted Radiotherapy with 131I-MIBG and Arsenic Trioxide in Patients with Resistant Neuroblastoma or Malignant Chromaffin Cell Tumors
[Protocol 04-148] 		Modak, Shakeel
  • Neuroblastoma
A Phase I Study of Intraperitoneal Radioimmunotherapy with 131I-8H9 for Patients with Desmoplastic Small Round Cell Tumors and Other Solid Peritoneal Tumors
[Protocol 09-090] 		Modak, Shakeel
On Our Blog